Financial News
Press Releases about Arrowhead Pharma
![](https://mms.businesswire.com/media/20220427005098/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Pharmaceuticals to Host Pulmonary R&D Day
April 27, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220426005404/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220425005291/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220420005909/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220406005336/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220401005135/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220324005293/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220315005352/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220224005435/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220221005057/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20220218005420/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20220218005072/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220217005207/en/1362803/5/ah_logo_cmyk.jpg)
Arrowhead Presents New Clinical Data on ARO-HIF2 at ASCO GU 2022
February 17, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220202005863/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Pharmaceuticals Reports Fiscal 2022 First Quarter Results
February 02, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220124005250/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220121005458/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220112005427/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20211220005220/en/1311046/4/2021_1210_-_Arrowhead_-_Aerial_East_-_Press_Release_Update.jpg)
![](https://mms.businesswire.com/media/20211217005630/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20211130006012/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20211122006586/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Pharmaceuticals Reports Fiscal 2021 Year End Results
November 22, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211122006522/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20211117005898/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Announces JNJ-75220795 in Development for NASH
November 17, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211115005639/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20211115005284/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Presents New Clinical Data on ARO-APOC3 at AHA 2021
November 15, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211112005374/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20211112005367/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20211101005860/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Year End Results
November 01, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211101005259/en/523535/5/ah_logo_cmyk.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.